BioCryst Pharmaceuticals (NASDAQ:BCRX) Posts Quarterly Earnings Results, Beats Expectations By $0 01 EPS themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Needham & Company LLC in a report issued on Thursday, Benzinga reports. They currently have a $12.00 price target on the biotechnology company’s stock, down from their prior price target of $14.00. Needham & Company LLC’s price target […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report)’s share price rose 4.6% on Friday . The stock traded as high as $7.50 and last traded at $7.50. Approximately 575,777 shares traded hands during trading, a decline of 80% from the average daily volume of 2,812,537 shares. The stock had previously closed at $7.17. Analyst Ratings […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 35,580,000 shares, an increase of 10.2% from the May 15th total of 32,300,000 shares. Based on an average daily trading volume, of 2,730,000 shares, the days-to-cover ratio […]
Fisher Asset Management LLC cut its holdings in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) by 14.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 4,431,114 shares of the biotechnology company’s stock after selling 732,731 shares during the period. Fisher Asset Management LLC’s holdings in BioCryst Pharmaceuticals were worth $50,869,000 at the […]